pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi: 10.3322/caac.21332.
   PubMed Web of Science ®Google Scholar
• Zaimy MA, Saffarzadeh N, Mohammadi A, et al. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017;24(6):233–243. doi: 10.1038/cgt.2017.16.
   PubMed Web of Science ®Google Scholar
• Sambrani R, Abdolalizadeh J, Kohan L, et al. Recent advances in the application of probiotic yeasts, particularly saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancer. Mol Biol Rep. 2021;48(1):951–960. doi: 10.1007/s11033-020-06110-1.
   PubMed Web of Science ®Google Scholar
• Alshememry AK, El-Tokhy SS, Unsworth LD. Using properties of tumor microenvironments for controlling local, on-demand delivery from biopolymer-based nanocarriers. Curr Pharm Des. 2017;23(35):5358–5391. doi: 10.2174/1381612823666170522100545.
   PubMed Web of Science ®Google Scholar
• Kopeckova K, Eckschlager T, Sirc J, et al. Nanodrugs used in cancer therapy. Biomed Pap. 2019;163(2):122–131. doi: 10.5507/bp.2019.010.
   PubMed Web of Science ®Google Scholar
• Pantshwa JM, Kondiah PPD, Choonara YE, et al. Nanodrug delivery systems for the treatment of ovarian cancer. Cancers. 2020;12(1):213. doi: 10.3390/cancers12010213.
   PubMed Web of Science ®Google Scholar
• Ho BN, Pfeffer CM, Singh ATK. Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer Res. 2017;37(11):5975–5981. doi: 10.21873/anticanres.12044.
   PubMed Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, et al. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6):673–692. doi: 10.2217/nnm.16.5.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Waters AK, Kalyan P, et al. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine. 2019;14:1937–1952. doi: 10.2147/IJN.S198353.
   PubMed Web of Science ®Google Scholar
• Salatin S, Barar J, Barzegar-Jalali M, et al. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery. Arch Pharm Res. 2016;39(9):1181–1192. doi: 10.1007/s12272-016-0782-0.
   PubMed Web of Science ®Google Scholar
• Yang YQ, Zhao B, Li ZD, et al. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(epsilon-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery. Acta Biomater. 2013;9(8):7679–7690. doi: 10.1016/j.actbio.2013.05.006.
   PubMed Web of Science ®Google Scholar
• Surnar B, Jayakannan M. Structural engineering of biodegradable PCL block copolymer nanoassemblies for enzyme-controlled drug delivery in cancer cells. ACS Biomater Sci Eng. 2016;2(11):1926–1941. doi: 10.1021/acsbiomaterials.6b00310.
   PubMed Web of Science ®Google Scholar
• Wang F, Li C, Cheng J, et al. Recent advances on inorganic nanoparticle-based cancer therapeutic agents. Int J Environ Res Public Health. 2016;13(12):1182.
   Web of Science ®Google Scholar
• Amreddy N, Babu A, Muralidharan R, et al. Recent advances in nanoparticle-based cancer drug and gene delivery. Adv Cancer Res. 2018;137:115–170.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao J, Tan T, et al. Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review. Int J Nanomedicine. 2020;15:2563–2582. doi: 10.2147/IJN.S243223.
   PubMed Web of Science ®Google Scholar
• Khodaei T, Inamdar S, Suresh AP, et al. Drug delivery for metabolism targeted cancer immunotherapy. Adv Drug Deliv Rev. 2022;184:114242. doi: 10.1016/j.addr.2022.114242.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang Y, Yu H, et al. Multifunctional theranostic nanoparticles derived from fruit-extracted anthocyanins with dynamic disassembly and elimination abilities. ACS Nano. 2018;12(8):8255–8265. doi: 10.1021/acsnano.8b03525.
   PubMed Web of Science ®Google Scholar
• Kang H, Rho S, Stiles WR, et al. Size-dependent EPR effect of polymeric nanoparticles on tumor targeting. Adv Healthc Mater. 2020;9(1):e1901223. doi: 10.1002/adhm.201901223.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang R, Liu G, et al. Redox-responsive self-assembled nanoparticles for cancer therapy. Adv Healthc Mater. 2020;9(20):e2000605. doi: 10.1002/adhm.202000605.
   PubMed Web of Science ®Google Scholar
• Hakeem A, Zahid F, Zhan G, et al. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release. Int J Nanomedicine. 2018;13:1029–1040. doi: 10.2147/IJN.S146955.
   PubMed Web of Science ®Google Scholar
• Han SS, Li ZY, Zhu JY, et al. Dual-pH sensitive charge-reversal polypeptide micelles for tumor-triggered targeting uptake and nuclear drug delivery. Small. 2015;11(21):2543–2554. doi: 10.1002/smll.201402865.
   PubMed Web of Science ®Google Scholar
• Zhao D, Li B, Han J, et al. PH responsive polypeptide based polymeric micelles for anticancer drug delivery. J Biomed Mater Res A. 2015;103(9):3045–3053. doi: 10.1002/jbm.a.35434.
   PubMed Web of Science ®Google Scholar
• Pan J, Cui Z. Self-assembled nanoparticles: exciting platforms for vaccination. Biotechnol J. 2020;15(12):e2000087. doi: 10.1002/biot.202000087.
   PubMed Web of Science ®Google Scholar
• Zheng K, Liu X, Liu H, et al. Novel pH-triggered doxorubicin-releasing nanoparticles self-assembled by functionalized beta-cyclodextrin and amphiphilic phthalocyanine for anticancer therapy. ACS Appl Mater Interfaces. 2021;13(9):10674–10688. doi: 10.1021/acsami.0c19027.
   PubMed Web of Science ®Google Scholar
• Varma LT, Singh N, Gorain B, et al. Recent advances in self-assembled nanoparticles for drug delivery. Curr Drug Deliv. 2020;17(4):279–291. doi: 10.2174/1567201817666200210122340.
   PubMed Web of Science ®Google Scholar
• Dutta D, Ke W, Xi L, et al. Block copolymer prodrugs: synthesis, self-assembly, and applications for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(1):e1585.
   PubMed Web of Science ®Google Scholar
• Li G, Sun B, Li Y, et al. Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery. Small. 2021;17(52):e2101460. doi: 10.1002/smll.202101460.
   PubMed Web of Science ®Google Scholar
• Jangid AK, Pooja D, Jain P, et al. Self-assembled and pH-responsive polymeric nanomicelles impart effective delivery of paclitaxel to cancer cells. RSC Adv. 2021;11(23):13928–13939. doi: 10.1039/d1ra01574e.
   PubMed Web of Science ®Google Scholar
• Kundu M, Majumder R, Das CK, et al. Natural products based nanoformulations for cancer treatment: current evolution in Indian research. Biomed Mater. 2021;16(4):044101. doi: 10.1088/1748-605X/abe8f2.
   Web of Science ®Google Scholar
• Wang Y, Sun S, Zhang Z, et al. Nanomaterials for cancer precision medicine. Adv Mater. 2018;30(17):e1705660.
   PubMed Web of Science ®Google Scholar
• Wang D, Jiang W. Preparation of chitosan-based nanoparticles for enzyme immobilization. Int J Biol Macromol. 2019;126:1125–1132. doi: 10.1016/j.ijbiomac.2018.12.243.
   PubMed Web of Science ®Google Scholar
• Duong VA, Nguyen TT, Maeng HJ. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules. 2020;25(20):4781. doi: 10.3390/molecules25204781.
   PubMed Web of Science ®Google Scholar
• Zoqlam R, Morris CJ, Akbar M, et al. Evaluation of the benefits of microfluidic-assisted preparation of polymeric nanoparticles for DNA delivery. Mater Sci Eng C Mater Biol Appl. 2021;127:112243. doi: 10.1016/j.msec.2021.112243.
   PubMed Web of Science ®Google Scholar
• Fallacara AL, Mancini A, Zamperini C, et al. Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line. Bioorg Med Chem Lett. 2017;27(14):3196–3200. doi: 10.1016/j.bmcl.2017.05.015.
   PubMed Web of Science ®Google Scholar
• Ekiz MS, Cinar G, Khalily MA, et al. Self-assembled peptide nanostructures for functional materials. Nanotechnology. 2016;27(40):402002. doi: 10.1088/0957-4484/27/40/402002.
   PubMed Web of Science ®Google Scholar
• Mendes AC, Baran ET, Reis RL, et al. Self-assembly in nature: using the principles of nature to create complex nanobiomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(6):582–612. doi: 10.1002/wnan.1238.
   PubMed Web of Science ®Google Scholar
• Larson N, Greish K, Bauer H, et al. Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin. Int J Pharm. 2011;420(1):111–117. doi: 10.1016/j.ijpharm.2011.08.011.
   PubMedGoogle Scholar
• Shi J, Xiao Z, Kamaly N, et al. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res. 2011;44(10):1123–1134. doi: 10.1021/ar200054n.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li Q, Wu Y, et al. Molecularly stimuli-responsive self-assembled peptide nanoparticles for targeted imaging and therapy. ACS Nano. 2023;17(9):8004–8025. doi: 10.1021/acsnano.3c01452.
   PubMed Web of Science ®Google Scholar
• Qiao L, Yang H, Gao S, et al. Research progress on self-assembled nanodrug delivery systems. J Mater Chem B. 2022;10(12):1908–1922. doi: 10.1039/d1tb02470a.
   PubMed Web of Science ®Google Scholar
• Zhang S, Pelligra CI, Feng X, et al. Directed assembly of hybrid nanomaterials and nanocomposites. Adv Mater. 2018;30(18):e1705794. doi: 10.1002/adma.201705794.
   PubMed Web of Science ®Google Scholar
• Yadav S, Sharma AK, Kumar P. Nanoscale self-assembly for therapeutic delivery. Front Bioeng Biotechnol. 2020;8:127. doi: 10.3389/fbioe.2020.00127.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang Q, Liu X, et al. A study of hydrophobically modified pullulan nanoparticles with different hydrophobic densities on the effect of anti-colon cancer cell efficiency. J Biomed Nanotechnol. 2021;17(10):1972–1983. doi: 10.1166/jbn.2021.3173.
   PubMed Web of Science ®Google Scholar
• Sha L, Wang D, Mao Y, et al. Hydrophobic interaction mediated coating of pluronics on mesoporous silica nanoparticle with stimuli responsiveness for cancer therapy. Nanotechnology. 2018;29(34):345101. doi: 10.1088/1361-6528/aac6b1.
   PubMed Web of Science ®Google Scholar
• Jang JD, Bae M, Do C, et al. Self-Assembly of 2D gold nanoparticle superlattice in a polymer vesicle layer driven by hydrophobic interaction. J Phys Chem Lett. 2021;12(28):6736–6743. doi: 10.1021/acs.jpclett.1c01684.
   PubMed Web of Science ®Google Scholar
• Derrien TL, Zhang M, Dorion PO, et al. Assembly dynamics of plasmonic DNA-capped gold nanoparticle monolayers. Langmuir. 2018;34(49):14711–14720. doi: 10.1021/acs.langmuir.8b00484.
   PubMed Web of Science ®Google Scholar
• Meng D, Zhang L, Wang Q, et al. Self-assembly of phycoerythrin with oligochitosan by electrostatic interaction for stabilization of phycoerythrin. J Agric Food Chem. 2021;69(43):12818–12827. doi: 10.1021/acs.jafc.1c05205.
   PubMed Web of Science ®Google Scholar
• Sahoo JK, VandenBerg MA, Ruiz Bello EE, et al. Electrostatic-driven self-sorting and nanostructure speciation in self-assembling tetrapeptides. Nanoscale. 2019;11(35):16534–16543. doi: 10.1039/c9nr03440d.
   PubMed Web of Science ®Google Scholar
• Nagy PI. Competing intramolecular vs. intermolecular hydrogen bonds in solution. Int J Mol Sci. 2014;15(11):19562–19633. doi: 10.3390/ijms151119562.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Rao Z, et al. Study on the stability and oral bioavailability of curcumin loaded (−)-epigallocatechin-3-gallate/poly(N-vinylpyrrolidone) nanoparticles based on hydrogen bonding-driven self-assembly. Food Chem. 2022;378:132091. doi: 10.1016/j.foodchem.2022.132091.
   PubMed Web of Science ®Google Scholar
• Le Z, Chen Y, Han H, et al. Hydrogen-bonded tannic acid-based anticancer nanoparticle for enhancement of oral chemotherapy. ACS Appl Mater Interfaces. 2018;10(49):42186–42197. doi: 10.1021/acsami.8b18979.
   PubMed Web of Science ®Google Scholar
• Chen S, Sun C, Wang Y, et al. Quercetagetin-loaded composite nanoparticles based on zein and hyaluronic acid: formation, characterization, and physicochemical stability. J Agric Food Chem. 2018;66(28):7441–7450. doi: 10.1021/acs.jafc.8b01046.
   PubMed Web of Science ®Google Scholar
• Wang T, Meng Q, Lin L, et al. Self-assembled dehydropeptide nanocarrier as a delivery system for antitumor drug temozolomide. Bioorg Chem. 2022;124:105842. doi: 10.1016/j.bioorg.2022.105842.
   PubMed Web of Science ®Google Scholar
• Bishop KJ, Wilmer CE, Soh S, et al. Nanoscale forces and their uses in self-assembly. Small. 2009;5(14):1600–1630. doi: 10.1002/smll.200900358.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Chen Y, Tian D, et al. Fabrication and characterization of lignin-xylan hybrid nanospheres as pesticide carriers with enzyme-mediated release property. Soft Matter. 2020;16(39):9083–9093. doi: 10.1039/d0sm01402h.
   Web of Science ®Google Scholar
• Kang W, Ji Y, Cheng Y. Van der Waals force-driven indomethacin-ss-paclitaxel nanodrugs for reversing multidrug resistance and enhancing NSCLC therapy. Int J Pharm. 2021;603:120691. doi: 10.1016/j.ijpharm.2021.120691.
   PubMedGoogle Scholar
• Li Y, Yang L. Driving forces for drug loading in drug carriers. J Microencapsul. 2015;32(3):255–272. doi: 10.3109/02652048.2015.1010459.
   PubMed Web of Science ®Google Scholar
• Behl G, Kumar P, Sikka M, et al. PEG-coumarin nanoaggregates as pi-pi stacking derived small molecule lipophile containing self-assemblies for anti-tumour drug delivery. J Biomater Sci Polym Ed. 2018;29(4):360–375. doi: 10.1080/09205063.2017.1421346.
   PubMed Web of Science ®Google Scholar
• Wu L, Shi Y, Ni Z, et al. Preparation of a self-assembled rhein-doxorubicin nanogel targeting mitochondria and investigation on its antihepatoma activity. Mol Pharm. 2022;19(1):35–50. doi: 10.1021/acs.molpharmaceut.1c00565.
   PubMedGoogle Scholar
• Bujosa S, Castellanos E, Frontera A, et al. Self-assembly of amphiphilic aryl-squaramides in water driven by dipolar pi-pi interactions. Org Biomol Chem. 2020;18(5):888–894. doi: 10.1039/c9ob02085c.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Huang J, He S, et al. One-step self-assembly of curcumin-loaded zein/sophorolipid nanoparticles: physicochemical stability, redispersibility, solubility and bioaccessibility. Food Funct. 2021;12(13):5719–5730. doi: 10.1039/d1fo00942g.
   PubMed Web of Science ®Google Scholar
• Li M, Liu Y, Liu Y, et al. pH-driven self-assembly of alcohol-free curcumin-loaded zein-propylene glycol alginate complex nanoparticles. Int J Biol Macromol. 2022;213:1057–1067. doi: 10.1016/j.ijbiomac.2022.06.046.
   PubMed Web of Science ®Google Scholar
• Bhullar S, Goyal N, Gupta S. In-vitro pH-responsive release of imatinib from iron-supplement coated anatase TiO(2) nanoparticles. Sci Rep. 2022;12(1):4600. doi: 10.1038/s41598-022-08090-7.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu X, Li D, et al. Smart pH-responsive polyhydralazine/bortezomib nanoparticles for remodeling tumor microenvironment and enhancing chemotherapy. Biomaterials. 2022;288:121737. doi: 10.1016/j.biomaterials.2022.121737.
   PubMed Web of Science ®Google Scholar
• Liao J, Zheng H, Fei Z, et al. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin. Int J Biol Macromol. 2018;113:737–747. doi: 10.1016/j.ijbiomac.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Kumar A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32(4):693–710. doi: 10.1016/j.biotechadv.2013.11.009.
   PubMed Web of Science ®Google Scholar
• Deirram N, Zhang C, Kermaniyan SS, et al. pH-responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun. 2019;40(10):e1800917. doi: 10.1002/marc.201800917.
   PubMed Web of Science ®Google Scholar
• Wu W, Luo L, Wang Y, et al. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications. Theranostics. 2018;8(11):3038–3058. doi: 10.7150/thno.23459.
   PubMed Web of Science ®Google Scholar
• Dalela M, Shrivastav TG, Kharbanda S, et al. pH-sensitive biocompatible nanoparticles of paclitaxel-conjugated poly(styrene-co-maleic acid) for anticancer drug delivery in solid tumors of syngeneic mice. ACS Appl Mater Interfaces. 2015;7(48):26530–26548. doi: 10.1021/acsami.5b07764.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zheng C, Wang L, et al. Covalent self-assembled nanoparticles with pH-dependent enhanced tumor retention and drug release for improving tumor therapeutic efficiency. J Mater Chem B. 2017;5(11):2133–2144. doi: 10.1039/c6tb02833k.
   PubMed Web of Science ®Google Scholar
• Sauraj, Kumar SU, Kumar V, et al. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy. Carbohydr Polym. 2018;188:252–259. doi: 10.1016/j.carbpol.2018.02.006.
   PubMed Web of Science ®Google Scholar
• Saha B, Choudhury N, Seal S, et al. Aromatic nitrogen mustard-based autofluorescent amphiphilic brush copolymer as pH-responsive drug delivery vehicle. Biomacromolecules. 2019;20(1):546–557. doi: 10.1021/acs.biomac.8b01468.
   PubMed Web of Science ®Google Scholar
• She W, Li N, Luo K, et al. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials. 2013;34(9):2252–2264. doi: 10.1016/j.biomaterials.2012.12.017.
   PubMed Web of Science ®Google Scholar
• Liu N, Han J, Zhang X, et al. pH-responsive zwitterionic polypeptide as a platform for anti-tumor drug delivery. Colloids Surf B Biointerfaces. 2016;145:401–409. doi: 10.1016/j.colsurfb.2016.05.027.
   PubMed Web of Science ®Google Scholar
• Wei X, Luo Q, Sun L, et al. Enzyme- and pH-sensitive branched polymer-doxorubicin conjugate-based nanoscale drug delivery system for cancer therapy. ACS Appl Mater Interfaces. 2016;8(18):11765–11778. doi: 10.1021/acsami.6b02006.
   PubMed Web of Science ®Google Scholar
• Pillarisetti S, Maya S, Sathianarayanan S, et al. Tunable pH and redox-responsive drug release from curcumin conjugated gamma-polyglutamic acid nanoparticles in cancer microenvironment. Colloids Surf B Biointerfaces. 2017;159:809–819. doi: 10.1016/j.colsurfb.2017.08.057.
   PubMed Web of Science ®Google Scholar
• Yuan X, Peng S, Lin W, et al. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery. J Colloid Interface Sci. 2019;555:82–93. doi: 10.1016/j.jcis.2019.07.061.
   PubMed Web of Science ®Google Scholar
• Liu P, Wu Q, Li Y, et al. DOX-conjugated keratin nanoparticles for pH-sensitive drug delivery. Colloids Surf B Biointerfaces. 2019;181:1012–1018. doi: 10.1016/j.colsurfb.2019.06.057.
   PubMed Web of Science ®Google Scholar
• Bian Y, Guo D. Targeted therapy for hepatocellular carcinoma: co-delivery of sorafenib and curcumin using lactosylated pH-responsive nanoparticles. Drug Des Devel Ther. 2020;14:647–659. doi: 10.2147/DDDT.S238955.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yan C, Chen Z, et al. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery. J Colloid Interface Sci. 2019;540:66–77. doi: 10.1016/j.jcis.2019.01.021.
   PubMed Web of Science ®Google Scholar
• Luo F, Fan Z, Yin W, et al. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy. Mater Sci Eng C Mater Biol Appl. 2019;105:110107. doi: 10.1016/j.msec.2019.110107.
   PubMed Web of Science ®Google Scholar
• Xie J, Fan Z, Li Y, et al. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Int J Nanomedicine. 2018;13:1381–1398. doi: 10.2147/IJN.S152312.
   PubMed Web of Science ®Google Scholar
• Rahimi S, Khoee S, Ghandi M. Preparation and characterization of rod-like chitosan-quinoline nanoparticles as pH-responsive nanocarriers for quercetin delivery. Int J Biol Macromol. 2019;128:279–289. doi: 10.1016/j.ijbiomac.2019.01.137.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu L, Dong B, et al. Multi-stimuli-responsive biohybrid nanoparticles with cross-linked albumin coronae self-assembled by a polymer-protein biodynamer. Acta Biomater. 2017;54:259–270. doi: 10.1016/j.actbio.2017.03.009.
   PubMed Web of Science ®Google Scholar
• Leong J, Chin W, Ke X, et al. Disease-directed design of biodegradable polymers: reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery. Nanomedicine. 2018;14(8):2666–2677. doi: 10.1016/j.nano.2018.06.015.
   PubMed Web of Science ®Google Scholar
• Mu J, Zhong H, Zou H, et al. Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: effect of PEG length on antitumor efficacy. J Control Release. 2020;326:265–275. doi: 10.1016/j.jconrel.2020.07.022.
   PubMed Web of Science ®Google Scholar
• Gao C, Tang F, Gong G, et al. pH-responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Nanoscale. 2017;9(34):12533–12542. doi: 10.1039/c7nr03611f.
   PubMed Web of Science ®Google Scholar
• Kim HK, Van den Bossche J, Hyun SH, et al. Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity. Bioconjug Chem. 2012;23(10):2071–2077. doi: 10.1021/bc300266y.
   PubMed Web of Science ®Google Scholar
• Wells CM, Harris M, Choi L, et al. Stimuli-responsive drug release from smart polymers. J Funct Biomater. 2019;10(3):34. doi: 10.3390/jfb10030034.
   PubMed Web of Science ®Google Scholar
• Ulrich S. Growing prospects of dynamic covalent chemistry in delivery applications. Acc Chem Res. 2019;52(2):510–519. doi: 10.1021/acs.accounts.8b00591.
   PubMed Web of Science ®Google Scholar
• Drożdż W, Bouillon C, Kotras C, et al. Generation of multicomponent molecular cages using simultaneous dynamic covalent reactions. Chemistry. 2017;23(71):18010–18018. doi: 10.1002/chem.201703868.
   PubMed Web of Science ®Google Scholar
• Siddique S, Chow JCL. Application of nanomaterials in biomedical imaging and cancer therapy. Nanomaterials. 2020;10(9):1700. doi: 10.3390/nano10091700.
   Web of Science ®Google Scholar
• Du H, Liu M, Yang X, et al. The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery. Drug Discov Today. 2015;20(8):1004–1011. doi: 10.1016/j.drudis.2015.03.002.
   PubMed Web of Science ®Google Scholar
• Gorchakov AA, Kulemzin SV, Kochneva GV, et al. Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer. Eur Urol. 2020;77(3):299–308. doi: 10.1016/j.eururo.2019.08.014.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53(46):12320–12364. doi: 10.1002/anie.201403036.
   PubMed Web of Science ®Google Scholar
• Ang CY, Tan SY, Teh C, et al. Redox and pH dual responsive polymer based nanoparticles for in vivo drug delivery. Small. 2017;13(7):10. doi: 10.1002/smll.201602379.
   Web of Science ®Google Scholar
• Dube T, Mandal S, Panda JJ. Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery. Amino Acids. 2017;49(5):975–993. doi: 10.1007/s00726-017-2403-8.
   PubMed Web of Science ®Google Scholar
• Yan J, Su T, Cheng F, et al. Multifunctional nanoparticles self-assembled from polyethylenimine-based graft polymers as efficient anticancer drug delivery. Colloids Surf B Biointerfaces. 2017;155:118–127. doi: 10.1016/j.colsurfb.2017.02.030.
   PubMed Web of Science ®Google Scholar
• Liu KF, Liu YX, Dai L, et al. A novel self-assembled pH-sensitive targeted nanoparticle platform based on antibody-4arm-polyethylene glycol-pterostilbene conjugates for co-delivery of anticancer drugs. J Mater Chem B. 2018;6(4):656–665. doi: 10.1039/c7tb02485a.
   PubMed Web of Science ®Google Scholar
• Yang H, Shen W, Liu W, et al. PEGylated poly(alpha-lipoic acid) loaded with doxorubicin as a pH and reduction dual responsive nanomedicine for breast cancer therapy. Biomacromolecules. 2018;19(11):4492–4503. doi: 10.1021/acs.biomac.8b01394.
   PubMed Web of Science ®Google Scholar
• Li Y, Hou H, Zhang P, et al. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy. Drug Deliv. 2020;27(1):1044–1053. doi: 10.1080/10717544.2020.1785049.
   PubMed Web of Science ®Google Scholar
• Zhang J, Song H, Ji S, et al. NO prodrug-conjugated, self-assembled, pH-responsive and galactose receptor targeted nanoparticles for co-delivery of nitric oxide and doxorubicin. Nanoscale. 2018;10(9):4179–4188. doi: 10.1039/c7nr08176f.
   PubMed Web of Science ®Google Scholar
• Li H, Wei R, Yan GH, et al. Smart self-assembled nanosystem based on water-soluble pillararene and rare-earth-doped upconversion nanoparticles for pH-responsive drug delivery. ACS Appl Mater Interfaces. 2018;10(5):4910–4920. doi: 10.1021/acsami.7b14193.
   PubMed Web of Science ®Google Scholar
• Zhong T, Yao X, Zhang S, et al. A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic. Sci Rep. 2016;6(1):36614. doi: 10.1038/srep36614.
   PubMedGoogle Scholar
• Zhang Y, Cui Z, Mei H, et al. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer. Carbohydr Polym. 2019;219:143–154. doi: 10.1016/j.carbpol.2019.04.041.
   PubMed Web of Science ®Google Scholar
• Sun H, Nai J, Deng B, et al. Angelica sinensis polysaccharide-based nanoparticles for liver-targeted delivery of oridonin. Molecules. 2024;29(3):731. doi: 10.3390/molecules29030731.
   Web of Science ®Google Scholar
• Chen Y, Su M, Li Y, et al. Enzymatic PEG-poly(amine-co-disulfide ester) nanoparticles as pH- and redox-responsive drug nanocarriers for efficient antitumor treatment. ACS Appl Mater Interfaces. 2017;9(36):30519–30535. doi: 10.1021/acsami.7b10148.
   PubMed Web of Science ®Google Scholar
• Liu N, Li B, Gong C, et al. A pH- and thermo-responsive poly(amino acid)-based drug delivery system. Colloids Surf B Biointerfaces. 2015;136:562–569. doi: 10.1016/j.colsurfb.2015.09.057.
   PubMed Web of Science ®Google Scholar
• Wu M, Cao Z, Zhao Y, et al. Novel self-assembled pH-responsive biomimetic nanocarriers for drug delivery. Mater Sci Eng C Mater Biol Appl. 2016;64:346–353. doi: 10.1016/j.msec.2016.03.099.
   PubMed Web of Science ®Google Scholar
• Ye Z, Zhang Q, Wang S, et al. Tumour-targeted drug delivery with mannose-functionalized nanoparticles self-assembled from amphiphilic beta-cyclodextrins. Chemistry. 2016;22(43):15216–15221. doi: 10.1002/chem.201603294.
   PubMed Web of Science ®Google Scholar
• He YJ, Xing L, Cui PF, et al. Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer. Biomaterials. 2017;113:266–278. doi: 10.1016/j.biomaterials.2016.11.001.
   PubMed Web of Science ®Google Scholar
• Raja MA, Arif M, Feng C, et al. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers. J Biomater Appl. 2017;31(8):1182–1195. doi: 10.1177/0885328216681184.
   PubMed Web of Science ®Google Scholar
• Liu KF, Liu YX, Li CX, et al. Self-assembled pH and redox dual responsive carboxymethylcellulose-based polymeric nanoparticles for efficient anticancer drug codelivery. ACS Biomater Sci Eng. 2018;4(12):4200–4207. doi: 10.1021/acsbiomaterials.8b00920.
   PubMed Web of Science ®Google Scholar
• Cheng C, Meng Y, Zhang Z, et al. pH responsible and fluorescent Cy5.5-PEG-g-A-HA/CDDP complex nanoparticles: synthesis, characterization, and application for targeted drug delivery. J Mater Sci Mater Med. 2019;30(6):58. doi: 10.1007/s10856-019-6260-8.
   PubMed Web of Science ®Google Scholar
• Chen PC, Lai JJ, Huang CJ. Bio-inspired amphoteric polymer for triggered-release drug delivery on breast cancer cells based on metal coordination. ACS Appl Mater Interfaces. 2021;13(22):25663–25673. doi: 10.1021/acsami.1c03191.
   PubMed Web of Science ®Google Scholar
• Chibh S, Katoch V, Kour A, et al. Continuous flow fabrication of Fmoc-cysteine based nanobowl infused core-shell like microstructures for pH switchable on-demand anti-cancer drug delivery. Biomater Sci. 2021;9(3):942–959. doi: 10.1039/d0bm01386b.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Zhu J, Wang J, et al. Self-assembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug. J Nanosci Nanotechnol. 2013;13(8):5935–5941. doi: 10.1166/jnn.2013.7537.
   PubMed Web of Science ®Google Scholar
• Xu C, Song RJ, Lu P, et al. pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy. Int J Nanomedicine. 2018;13:7229–7249. doi: 10.2147/IJN.S182197.
   PubMed Web of Science ®Google Scholar
• de Oliveira Pedro R, Goycoolea FM, Pereira S, et al. Synergistic effect of quercetin and pH-responsive DEAE-chitosan carriers as drug delivery system for breast cancer treatment. Int J Biol Macromol. 2018;106:579–586. doi: 10.1016/j.ijbiomac.2017.08.056.
   PubMed Web of Science ®Google Scholar
• He M, Potuck A, Kohn JC, et al. Self-assembled cationic biodegradable nanoparticles from pH-responsive amino-acid-based poly(ester urea urethane)s and their application as a drug delivery vehicle. Biomacromolecules. 2016;17(2):523–537. doi: 10.1021/acs.biomac.5b01449.
   PubMed Web of Science ®Google Scholar
• de Oliveira Pedro R, Hoffmann S, Pereira S, et al. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. Eur J Pharm Biopharm. 2018;131:203–210. doi: 10.1016/j.ejpb.2018.08.009.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wei Z, Zhao Z, et al. Design and development of graphene oxide nanoparticle/chitosan hybrids showing pH-sensitive surface charge-reversible ability for efficient intracellular doxorubicin delivery. ACS Appl Mater Interfaces. 2018;10(7):6608–6617. doi: 10.1021/acsami.7b16910.
   PubMed Web of Science ®Google Scholar
• Jin M, Jin G, Kang L, et al. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Int J Nanomedicine. 2018;13:2405–2426. doi: 10.2147/IJN.S161426.
   PubMed Web of Science ®Google Scholar
• Du C, Liang Y, Ma Q, et al. Intracellular tracking of drug release from pH-sensitive polymeric nanoparticles via FRET for synergistic chemo-photodynamic therapy. J Nanobiotechnology. 2019;17(1):113. doi: 10.1186/s12951-019-0547-2.
   PubMed Web of Science ®Google Scholar
• Qiao ZY, Zhang D, Hou CY, et al. A pH-responsive natural cyclopeptide RA-V drug formulation for improved breast cancer therapy. J Mater Chem B. 2015;3(22):4514–4523. doi: 10.1039/c5tb00445d.
   PubMed Web of Science ®Google Scholar
• Men W, Zhu P, Dong S, et al. Fabrication of dual pH/redox-responsive lipid-polymer hybrid nanoparticles for anticancer drug delivery and controlled release. Int J Nanomedicine. 2019;14:8001–8011. doi: 10.2147/IJN.S226798.
   PubMed Web of Science ®Google Scholar
• Bai Y, Liu CP, Chen D, et al. beta-Cyclodextrin-modified hyaluronic acid-based supramolecular self-assemblies for pH- and esterase- dual-responsive drug delivery. Carbohydr Polym. 2020;246:116654. doi: 10.1016/j.carbpol.2020.116654.
   PubMed Web of Science ®Google Scholar
• Singh PK, Chibh S, Dube T, et al. Arginine-alpha, beta-dehydrophenylalanine dipeptide nanoparticles for pH-responsive drug delivery. Pharm Res. 2018;35(2):35. doi: 10.1007/s11095-017-2299-8.
   PubMed Web of Science ®Google Scholar
• Pandit G, Roy K, Agarwal U, et al. Self-assembly mechanism of a peptide-based drug delivery vehicle. ACS Omega. 2018;3(3):3143–3155. doi: 10.1021/acsomega.7b01871.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zi Y, Lei J, et al. pH-responsive nanoparticles based on cholesterol/imidazole modified oxidized-starch for targeted anticancer drug delivery. Carbohydr Polym. 2020;233:115858. doi: 10.1016/j.carbpol.2020.115858.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fang F, Li L, et al. Self-assembled organic nanomaterials for drug delivery, bioimaging, and cancer therapy. ACS Biomater Sci Eng. 2020;6(9):4816–4833. doi: 10.1021/acsbiomaterials.0c00883.
   PubMed Web of Science ®Google Scholar
• Sun R, Fang L, Lv X, et al. In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor. Drug Deliv. 2021;28(1):2071–2084. doi: 10.1080/10717544.2021.1983077.
   PubMed Web of Science ®Google Scholar
• Vivek R, Nipun Babu V, Thangam R, et al. pH-responsive drug delivery of chitosan nanoparticles as tamoxifen carriers for effective anti-tumor activity in breast cancer cells. Colloids Surf B Biointerfaces. 2013;111:117–123. doi: 10.1016/j.colsurfb.2013.05.018.
   PubMed Web of Science ®Google Scholar
• Luo F, Fan Z, Yin W, et al. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy. Mater Sci Eng C. 2019;105:110107. doi: 10.1016/j.msec.2019.110107.
   PubMed Web of Science ®Google Scholar
• Lu B, Xiao F, Wang Z, et al. Redox-sensitive hyaluronic acid polymer prodrug nanoparticles for enhancing intracellular drug self-delivery and targeted cancer therapy. ACS Biomater Sci Eng. 2020;6(7):4106–4115. doi: 10.1021/acsbiomaterials.0c00762.
   PubMed Web of Science ®Google Scholar
• Zheng D, Zhao J, Li Y, et al. Self-assembled pH-sensitive nanoparticles based on Ganoderma lucidum polysaccharide-methotrexate conjugates for the co-delivery of anti-tumor drugs. ACS Biomater Sci Eng. 2021;7(8):3764–3773. doi: 10.1021/acsbiomaterials.1c00663.
   PubMed Web of Science ®Google Scholar
• Pan K, Chen H, Baek SJ, et al. Self-assembled curcumin-soluble soybean polysaccharide nanoparticles: physicochemical properties and in vitro anti-proliferation activity against cancer cells. Food Chem. 2018;246:82–89. doi: 10.1016/j.foodchem.2017.11.002.
   PubMed Web of Science ®Google Scholar
• Xiong YX, Li N, Han MM, et al. Rhodiola rosea polysaccharides-based nanoparticles loaded with DOX boosts chemo-immunotherapy for triple-negative breast cancer by re-educating tumor-associated macrophages. Int J Biol Macromol. 2023;239:124110. doi: 10.1016/j.ijbiomac.2023.124110.
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhang Z, Guo J, et al. Polypeptide nanoparticles with pH-sheddable PEGylation for improved drug delivery. Langmuir. 2020;36(45):13656–13662. doi: 10.1021/acs.langmuir.0c02532.
   PubMed Web of Science ®Google Scholar
• Yoon S, Kim Y, Youn YS, et al. Transferrin-conjugated pH-responsive gamma-cyclodextrin nanoparticles for antitumoral topotecan delivery. Pharmaceutics. 2020;12(11):1109. doi: 10.3390/pharmaceutics12111109.
   PubMed Web of Science ®Google Scholar
• Zhi X, Liu P, Li Y, et al. One-step fabricated keratin nanoparticles as pH and redox-responsive drug nanocarriers. J Biomater Sci Polym Ed. 2018;29(15):1920–1934. doi: 10.1080/09205063.2018.1519987.
   PubMed Web of Science ®Google Scholar
• Han X, Wang L, Du J, et al. Keratin-dopamine conjugate nanoparticles as pH/GSH dual responsive drug carriers. J Biomater Sci Polym Ed. 2020;31(18):2318–2330. doi: 10.1080/09205063.2020.1803182.
   PubMed Web of Science ®Google Scholar
• Du J, Wang L, Han X, et al. Keratin-tannic acid complex nanoparticles as pH/GSH dual responsive drug carriers for doxorubicin. J Biomater Sci Polym Ed. 2021;32(9):1125–1139. doi: 10.1080/09205063.2021.1906074.
   PubMed Web of Science ®Google Scholar
• Saleh T, Soudi T, Shojaosadati SA. Redox responsive curcumin-loaded human serum albumin nanoparticles: preparation, characterization and in vitro evaluation. Int J Biol Macromol. 2018;114:759–766. doi: 10.1016/j.ijbiomac.2018.03.085.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Shojaosadati SA. A comparative and systematic approach to desolvation and self-assembly methods for synthesis of piperine-loaded human serum albumin nanoparticles. Colloids Surf B Biointerfaces. 2019;184:110534. doi: 10.1016/j.colsurfb.2019.110534.
   PubMed Web of Science ®Google Scholar
• Kumari P, Paul M, Bobde Y, et al. Albumin-based lipoprotein nanoparticles for improved delivery and anticancer activity of curcumin for cancer treatment. Nanomedicine. 2020;15(29):2851–2869. doi: 10.2217/nnm-2020-0232.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Safavi MS, Handali S, et al. Synergistic effect of self-assembled curcumin and piperine co-loaded human serum albumin nanoparticles on suppressing cancer cells. Drug Dev Ind Pharm. 2020;46(10):1647–1655. doi: 10.1080/03639045.2020.1820032.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wan S, Peng X, et al. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity. J Mater Chem B. 2020;8(17):3939–3948. doi: 10.1039/d0tb00327a.
   PubMed Web of Science ®Google Scholar
• Kumbham S, Paul M, Itoo A, et al. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma. Int J Pharm. 2022;614:121479. doi: 10.1016/j.ijpharm.2022.121479.
   PubMedGoogle Scholar
• Zhou P, Wu S, Hegazy M, et al. Engineered borate ester conjugated protein-polymer nanoconjugates for pH-responsive drug delivery. Mater Sci Eng C Mater Biol Appl. 2019;104:109914. doi: 10.1016/j.msec.2019.109914.
   PubMed Web of Science ®Google Scholar
• Wang D, Chen W, Li H, et al. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery. Int J Pharm. 2020;585:119456. doi: 10.1016/j.ijpharm.2020.119456.
   PubMed Web of Science ®Google Scholar
• Hao L, Zhou Q, Piao Y, et al. Albumin-binding prodrugs via reversible iminoboronate forming nanoparticles for cancer drug delivery. J Control Release. 2021;330:362–371. doi: 10.1016/j.jconrel.2020.12.035.
   PubMed Web of Science ®Google Scholar
• Liu Y, Qiao Z, Gao J, et al. Hydroxyapatite-bovine serum albumin-paclitaxel nanoparticles for locoregional treatment of osteosarcoma. Adv Healthc Mater. 2021;10(2):e2000573. doi: 10.1002/adhm.202000573.
   PubMed Web of Science ®Google Scholar
• Jafari A, Yan L, Mohamed MA, et al. Well-defined diblock poly(ethylene glycol)-b-poly(epsilon-caprolactone)-based polymer-drug conjugate micelles for pH-responsive delivery of doxorubicin. Materials. 2020;13(7):1510. doi: 10.3390/ma13071510.
   PubMed Web of Science ®Google Scholar
• Xiong D, Zhang X, Peng S, et al. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging. Colloids Surf B Biointerfaces. 2018;163:29–40.
   Web of Science ®Google Scholar
• Li F, Liang Y, Wang M, et al. Multifunctional nanoplatforms as cascade-responsive drug-delivery carriers for effective synergistic chemo-photodynamic cancer treatment. J Nanobiotechnology. 2021;19(1):140. doi: 10.1186/s12951-021-00876-7.
   PubMed Web of Science ®Google Scholar
• Luo Y, Yin X, Yin X, et al. Dual pH/redox-responsive mixed polymeric micelles for anticancer drug delivery and controlled release. Pharmaceutics. 2019;11(4):176. doi: 10.3390/pharmaceutics11040176.
   PubMed Web of Science ®Google Scholar
• Su Z, Xu Y, Wang Y, et al. A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release. Biomater Sci. 2019;7(9):3821–3831. doi: 10.1039/c9bm00825j.
   PubMed Web of Science ®Google Scholar
• Kaushik P, Priyadarshini E, Rawat K, et al. pH responsive doxorubucin loaded zein nanoparticle crosslinked pectin hydrogel as effective site-specific anticancer substrates. Int J Biol Macromol. 2020;152:1027–1037. doi: 10.1016/j.ijbiomac.2019.10.190.
   PubMed Web of Science ®Google Scholar
• Sahu P, Kashaw SK, Kushwah V, et al. pH responsive biodegradable nanogels for sustained release of bleomycin. Bioorg Med Chem. 2017;25(17):4595–4613. doi: 10.1016/j.bmc.2017.06.038.
   PubMed Web of Science ®Google Scholar
• Wang QS, Gao LN, Zhu XN, et al. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma. Theranostics. 2019;9(21):6239–6255. doi: 10.7150/thno.35972.
   PubMed Web of Science ®Google Scholar
• Luckanagul JA, Pitakchatwong C, Ratnatilaka Na Bhuket P, et al. Chitosan-based polymer hybrids for thermo-responsive nanogel delivery of curcumin. Carbohydr Polym. 2018;181:1119–1127. doi: 10.1016/j.carbpol.2017.11.027.
   PubMed Web of Science ®Google Scholar
• Lei C, Liu XR, Chen QB, et al. Hyaluronic acid and albumin based nanoparticles for drug delivery. J Control Release. 2021;331:416–433. doi: 10.1016/j.jconrel.2021.01.033.
   PubMed Web of Science ®Google Scholar
• Niu W, Xiao Q, Wang X, et al. A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy. Nano Lett. 2021;21(3):1484–1492. doi: 10.1021/acs.nanolett.0c04753.
   PubMed Web of Science ®Google Scholar
• Gu P, Liu Z, Sun Y, et al. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses. Int J Pharm. 2019;554:72–80. doi: 10.1016/j.ijpharm.2018.11.008.
   PubMedGoogle Scholar
• Tang H, Zhao W, Yu J, et al. Recent development of pH-responsive polymers for cancer nanomedicine. Molecules. 2018;24(1):4. doi: 10.3390/molecules24010004.
   PubMed Web of Science ®Google Scholar
• Liu X, Yang Y, Urban MW. Stimuli-responsive polymeric nanoparticles. Macromol Rapid Commun. 2017;38(13):10. doi: 10.1002/marc.201700030.
   Web of Science ®Google Scholar
• Marques C, Maurizi L, Borchard G, et al. Characterization challenges of self-assembled polymer-SPIONs nanoparticles: benefits of orthogonal methods. Int J Mol Sci. 2022;23(24):16124. doi: 10.3390/ijms232416124.
   PubMed Web of Science ®Google Scholar
• Paul P, Kolesinska B, Sujka W. Chitosan and its derivatives – biomaterials with diverse biological activity for manifold applications. Mini Rev Med Chem. 2019;19(9):737–750. doi: 10.2174/1389557519666190112142735.
   PubMed Web of Science ®Google Scholar
• Synowiecki J, Al-Khateeb NA. Production, properties, and some new applications of chitin and its derivatives. Crit Rev Food Sci Nutr. 2003;43(2):145–171. doi: 10.1080/10408690390826473.
   PubMed Web of Science ®Google Scholar
• Matalqah SM, Aiedeh K, Mhaidat NM, et al. Chitosan nanoparticles as a novel drug delivery system: a review article. Curr Drug Targets. 2020;21(15):1613–1624. doi: 10.2174/1389450121666200711172536.
   PubMed Web of Science ®Google Scholar
• Younes I, Rinaudo M. Chitin and chitosan preparation from marine sources. Structure, properties and applications. Mar Drugs. 2015;13(3):1133–1174. doi: 10.3390/md13031133.
   PubMed Web of Science ®Google Scholar
• Matica MA, Aachmann FL, Tøndervik A, et al. Chitosan as a wound dressing starting material: antimicrobial properties and mode of action. Int J Mol Sci. 2019;20(23):5889. doi: 10.3390/ijms20235889.
   PubMed Web of Science ®Google Scholar
• Tian B, Hua S, Liu J. Multi-functional chitosan-based nanoparticles for drug delivery: recent advanced insight into cancer therapy. Carbohydr Polym. 2023;315:120972. doi: 10.1016/j.carbpol.2023.120972.
   PubMed Web of Science ®Google Scholar
• Borges O, Cordeiro-da-Silva A, Tavares J, et al. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Eur J Pharm Biopharm. 2008;69(2):405–416. doi: 10.1016/j.ejpb.2008.01.019.
   PubMed Web of Science ®Google Scholar
• Bravo-Osuna I, Schmitz T, Bernkop-Schnürch A, et al. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int J Pharm. 2006;316(1–2):170–175. doi: 10.1016/j.ijpharm.2006.02.037.
   PubMed Web of Science ®Google Scholar
• Chen FP, Ou SY, Tang CH. Core-shell soy protein-soy polysaccharide complex (nano)particles as carriers for improved stability and sustained release of curcumin. J Agric Food Chem. 2016;64(24):5053–5059. doi: 10.1021/acs.jafc.6b01176.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang L, Yu H, et al. Recent progress on synthesis, property and application of modified chitosan: an overview. Int J Biol Macromol. 2016;88:333–344. doi: 10.1016/j.ijbiomac.2016.04.002.
   PubMed Web of Science ®Google Scholar
• Vasvani S, Kulkarni P, Rawtani D. Hyaluronic acid: a review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int J Biol Macromol. 2020;151:1012–1029. doi: 10.1016/j.ijbiomac.2019.11.066.
   PubMed Web of Science ®Google Scholar
• Huang G, Huang H. Application of hyaluronic acid as carriers in drug delivery. Drug Deliv. 2018;25(1):766–772. doi: 10.1080/10717544.2018.1450910.
   PubMed Web of Science ®Google Scholar
• Cai J, Fu J, Li R, et al. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles. Carbohydr Polym. 2019;208:356–364. doi: 10.1016/j.carbpol.2018.12.074.
   PubMed Web of Science ®Google Scholar
• Hou X, Zhong D, Chen H, et al. Recent advances in hyaluronic acid-based nanomedicines: preparation and application in cancer therapy. Carbohydr Polym. 2022;292:119662. doi: 10.1016/j.carbpol.2022.119662.
   PubMed Web of Science ®Google Scholar
• Xin Li J, Jiao Zhang M, Feng Shi J, et al. pH-sensitive nano-polyelectrolyte complexes with arthritic macrophage-targeting delivery of triptolide. Int J Pharm. 2023;632:122572. doi: 10.1016/j.ijpharm.2022.122572.
   PubMedGoogle Scholar
• Kang Z, Lee ST. Carbon dots: advances in nanocarbon applications. Nanoscale. 2019;11(41):19214–19224. doi: 10.1039/c9nr05647e.
   PubMed Web of Science ®Google Scholar
• Tian XT, Yin XB. Carbon dots, unconventional preparation strategies, and applications beyond photoluminescence. Small. 2019;15(48):e1901803. doi: 10.1002/smll.201901803.
   PubMed Web of Science ®Google Scholar
• Chowdhuri AR, Singh T, Ghosh SK, et al. Carbon dots embedded magnetic nanoparticles @chitosan @metal organic framework as a nanoprobe for pH sensitive targeted anticancer drug delivery. ACS Appl Mater Interfaces. 2016;8(26):16573–16583. doi: 10.1021/acsami.6b03988.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen X, Zhang X, et al. Carbon-quantum-dots-loaded mesoporous silica nanocarriers with pH-switchable zwitterionic surface and enzyme-responsive pore-cap for targeted imaging and drug delivery to tumor. Adv Healthc Mater. 2016;5(12):1401–1407. doi: 10.1002/adhm.201600002.
   PubMed Web of Science ®Google Scholar
• Chen SY, Song ZM, Feng RL. Recent development of copolymeric nano-drug delivery system for paclitaxel. Anticancer Agents Med Chem. 2020;20(18):2169–2189. doi: 10.2174/1871520620666200719001038.
   PubMed Web of Science ®Google Scholar
• Li J, Li M, Tian L, et al. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. Int J Pharm. 2020;578:119122. doi: 10.1016/j.ijpharm.2020.119122.
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Xu C, et al. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy. Acta Biomater. 2021;134:546–558. doi: 10.1016/j.actbio.2021.04.022.
   PubMed Web of Science ®Google Scholar
• Deng Y, Shavandi A, Okoro OV, et al. Alginate modification via click chemistry for biomedical applications. Carbohydr Polym. 2021;270:118360. doi: 10.1016/j.carbpol.2021.118360.
   PubMed Web of Science ®Google Scholar
• He L, Shang Z, Liu H, et al. Alginate-based platforms for cancer-targeted drug delivery. Biomed Res Int. 2020;2020:1487259–1487217. doi: 10.1155/2020/1487259.
   PubMed Web of Science ®Google Scholar
• Severino P, da Silva CF, Andrade LN, et al. Alginate nanoparticles for drug delivery and targeting. Curr Pharm Des. 2019;25(11):1312–1334. doi: 10.2174/1381612825666190425163424.
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Merino M, Shenol A, et al. Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model. Int J Pharm. 2019;556:1–8. doi: 10.1016/j.ijpharm.2018.11.070.
   PubMed Web of Science ®Google Scholar
• Dong Y, He Y, Fan D, et al. Preparation of pH-sensitive chitosan-deoxycholic acid-sodium alginate nanoparticles loaded with ginsenoside Rb(1) and its controlled release mechanism. Int J Biol Macromol. 2023;234:123736. doi: 10.1016/j.ijbiomac.2023.123736.
   PubMed Web of Science ®Google Scholar
• Gong H, Li W, Sun J, et al. A review on plant polysaccharide based on drug delivery system for construction and application, with emphasis on traditional Chinese medicine polysaccharide. Int J Biol Macromol. 2022;211:711–728. doi: 10.1016/j.ijbiomac.2022.05.087.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu J, Huang L, et al. Synergistic effects of antitumor efficacy via mixed nano-size micelles of multifunctional Bletilla striata polysaccharide-based copolymer and D-alpha-tocopheryl polyethylene glycol succinate. Int J Biol Macromol. 2020;154:499–510. doi: 10.1016/j.ijbiomac.2020.03.136.
   PubMed Web of Science ®Google Scholar
• Peng P, Yang K, Tong G, et al. Polysaccharide nanoparticles for targeted cancer therapies. Curr Drug Metab. 2018;19(9):781–792. doi: 10.2174/1389200219666180511153403.
   PubMed Web of Science ®Google Scholar
• Nai J, Zhang C, Shao H, et al. Extraction, structure, pharmacological activities and drug carrier applications of Angelica sinensis polysaccharide. Int J Biol Macromol. 2021;183:2337–2353. doi: 10.1016/j.ijbiomac.2021.05.213.
   PubMed Web of Science ®Google Scholar
• D’Souza AA, Devarajan PV. Asialoglycoprotein receptor mediated hepatocyte targeting – strategies and applications. J Control Release. 2015;203:126–139. doi: 10.1016/j.jconrel.2015.02.022.
   PubMed Web of Science ®Google Scholar
• Huang A, Yang XR, Chung WY, et al. Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5(1):146. doi: 10.1038/s41392-020-00264-x.
   PubMed Web of Science ®Google Scholar
• Ahmad MF. Ganoderma lucidum: persuasive biologically active constituents and their health endorsement. Biomed Pharmacother. 2018;107:507–519. doi: 10.1016/j.biopha.2018.08.036.
   PubMed Web of Science ®Google Scholar
• Luo H, Tan D, Peng B, et al. The pharmacological rationales and molecular mechanisms of Ganoderma lucidum polysaccharides for the therapeutic applications of multiple diseases. Am J Chin Med. 2022;50(1):53–90. doi: 10.1142/S0192415X22500033.
   PubMedGoogle Scholar
• Zheng D, Zhao J, Tao Y, et al. pH and glutathione dual responsive nanoparticles based on Ganoderma lucidum polysaccharide for potential programmable release of three drugs. Chem Eng J. 2020;389:124418.
   Web of Science ®Google Scholar
• Salarbashi D, Tafaghodi M, Bazzaz BSF, et al. Characterization of soluble soybean (SSPS) polysaccharide and development of eco-friendly SSPS/TiO2 nanoparticle bionanocomposites. Int J Biol Macromol. 2018;112:852–861. doi: 10.1016/j.ijbiomac.2018.01.182.
   PubMed Web of Science ®Google Scholar
• Lin D, Long X, Xiao L, et al. Study on the functional properties and structural characteristics of soybean soluble polysaccharides by mixed bacteria fermentation and microwave treatment. Int J Biol Macromol. 2020;157:561–568. doi: 10.1016/j.ijbiomac.2020.04.133.
   PubMed Web of Science ®Google Scholar
• Xu K, Yao P. Stable oil-in-water emulsions prepared from soy protein-dextran conjugates. Langmuir. 2009;25(17):9714–9720. doi: 10.1021/la900960g.
   PubMed Web of Science ®Google Scholar
• Chen FP, Ou SY, Chen Z, et al. Soy soluble polysaccharide as a nanocarrier for curcumin. J Agric Food Chem. 2017;65(8):1707–1714. doi: 10.1021/acs.jafc.6b05087.
   PubMed Web of Science ®Google Scholar
• Martínez-López AL, Pangua C, Reboredo C, et al. Protein-based nanoparticles for drug delivery purposes. Int J Pharm. 2020;581:119289. doi: 10.1016/j.ijpharm.2020.119289.
   PubMed Web of Science ®Google Scholar
• Kopac T. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: a critical review. Int J Biol Macromol. 2021;169:290–301. doi: 10.1016/j.ijbiomac.2020.12.108.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng K, Xuan G, et al. Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment. Int J Nanomedicine. 2018;13:7681–7695. doi: 10.2147/IJN.S181199.
   PubMed Web of Science ®Google Scholar
• Wang L, Du J, Han X, et al. Self-crosslinked keratin nanoparticles for pH and GSH dual responsive drug carriers. J Biomater Sci Polym Ed. 2020;31(15):1994–2006. doi: 10.1080/09205063.2020.1788371.
   PubMed Web of Science ®Google Scholar
• Ruan S, Qin L, Xiao W, et al. Acid-responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery. Adv Funct Mater. 2018;28(30):1802227.
   Web of Science ®Google Scholar
• Setyawati MI, Tay CY, Docter D, et al. Understanding and exploiting nanoparticles’ intimacy with the blood vessel and blood. Chem Soc Rev. 2015;44(22):8174–8199. doi: 10.1039/c5cs00499c.
   PubMed Web of Science ®Google Scholar
• Li H, Jia Y, Peng H, et al. Recent developments in dopamine-based materials for cancer diagnosis and therapy. Adv Colloid Interface Sci. 2018;252:1–20. doi: 10.1016/j.cis.2018.01.001.
   PubMed Web of Science ®Google Scholar
• Kunde SS, Wairkar S. Targeted delivery of albumin nanoparticles for breast cancer: a review. Colloids Surf B Biointerfaces. 2022;213:112422. doi: 10.1016/j.colsurfb.2022.112422.
   PubMed Web of Science ®Google Scholar
• Solanki R, Rostamabadi H, Patel S, et al. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: a critical review. Int J Biol Macromol. 2021;193(Pt A):528–540. doi: 10.1016/j.ijbiomac.2021.10.040.
   PubMedGoogle Scholar
• Hu W, Ying M, Zhang S, et al. Poly(amino acid)-based carrier for drug delivery systems. J Biomed Nanotechnol. 2018;14(8):1359–1374. doi: 10.1166/jbn.2018.2590.
   PubMedGoogle Scholar
• Gupta SS, Mishra V, Mukherjee MD, et al. Amino acid derived biopolymers: recent advances and biomedical applications. Int J Biol Macromol. 2021;188:542–567. doi: 10.1016/j.ijbiomac.2021.08.036.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Gahtori R, Govarthanan K, et al. Recent trends in biodegradable polyester nanomaterials for cancer therapy. Mater Sci Eng C. 2021;127:112198. doi: 10.1016/j.msec.2021.112198.
   PubMed Web of Science ®Google Scholar
• Turek A, Stoklosa K, Borecka A, et al. Designing biodegradable wafers based on poly(L-lactide-co-glycolide) and poly(glycolide-co-epsilon-caprolactone) for the prolonged and local release of idarubicin for the therapy of glioblastoma multiforme. Pharm Res. 2020;37(5):90. doi: 10.1007/s11095-020-02810-2.
   PubMed Web of Science ®Google Scholar
• Domańska IM, Oledzka E, Sobczak M. Sterilization process of polyester based anticancer-drug delivery systems. Int J Pharm. 2020;587:119663. doi: 10.1016/j.ijpharm.2020.119663.
   PubMedGoogle Scholar
• Qian Y, Zhang J, Xu R, et al. Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying celastrol and ferrocene for breast cancer treatment. Int J Biol Macromol. 2021;183:2215–2226. doi: 10.1016/j.ijbiomac.2021.05.204.
   PubMed Web of Science ®Google Scholar
• Li X, Li L, Huang Y, et al. Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma. Biomater Sci. 2017;5(10):2068–2078. doi: 10.1039/c7bm00395a.
   PubMed Web of Science ®Google Scholar
• Wu Y, Li J, Zhong X, et al. A pH-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy. Asian J Pharm Sci. 2022;17(2):206–218. doi: 10.1016/j.ajps.2021.12.003.
   PubMed Web of Science ®Google Scholar
• Park SC, Heo H, Jang MK. Polyethylenimine grafted-chitosan based gambogic acid copolymers for targeting cancer cells overexpressing transferrin receptors. Carbohydr Polym. 2022;277:118755. doi: 10.1016/j.carbpol.2021.118755.
   PubMed Web of Science ®Google Scholar
• Bondioli L, Ruozi B, Belletti D, et al. Sialic acid as a potential approach for the protection and targeting of nanocarriers. Expert Opin Drug Deliv. 2011;8(7):921–937. doi: 10.1517/17425247.2011.577061.
   PubMed Web of Science ®Google Scholar
• Wu D, Yang J, Xing Z, et al. Phenylboronic acid-functionalized polyamidoamine-mediated bcl-2 siRNA delivery for inhibiting the cell proliferation. Colloids Surf B Biointerfaces. 2016;146:318–325. doi: 10.1016/j.colsurfb.2016.06.034.
   PubMed Web of Science ®Google Scholar
• Li Y, Xiao W, Xiao K, et al. Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angew Chem Int Ed Engl. 2012;51(12):2864–2869. doi: 10.1002/anie.201107144.
   PubMed Web of Science ®Google Scholar
• Yang B, Jia H, Wang X, et al. Self-assembled vehicle construction via boronic acid coupling and host-guest interaction for serum-tolerant DNA transport and pH-responsive drug delivery. Adv Healthc Mater. 2014;3(4):596–608. doi: 10.1002/adhm.201300162.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang J, Chen X, et al. Phenylboronic acid-cross-linked nanoparticles with improved stability as dual acid-responsive drug carriers. Macromol Biosci. 2017;17(3):10.
   Web of Science ®Google Scholar
• Wang J, Liu LG, Jiao WQ, et al. Phenylboronic acid-conjugated chitosan nanoparticles for high loading and efficient delivery of curcumin. Carbohydr Polym. 2021;256:117497. doi: 10.1016/j.carbpol.2020.117497.
   PubMed Web of Science ®Google Scholar
• Li T, Lu XM, Zhang MR, et al. Peptide-based nanomaterials: self-assembly, properties and applications. Bioact Mater. 2022;11:268–282. doi: 10.1016/j.bioactmat.2021.09.029.
   PubMed Web of Science ®Google Scholar
• Jiang X, Fan X, Xu W, et al. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug. J Control Release. 2019;316:196–207. doi: 10.1016/j.jconrel.2019.10.031.
   PubMed Web of Science ®Google Scholar
• Gong Z, Liu X, Zhou B, et al. Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy. Colloids Surf B Biointerfaces. 2021;202:111673. doi: 10.1016/j.colsurfb.2021.111673.
   PubMed Web of Science ®Google Scholar
• Jia W, Liu R, Wang Y, et al. Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer. Acta Pharm Sin B. 2022;12(8):3354–3366. doi: 10.1016/j.apsb.2022.03.010.
   PubMed Web of Science ®Google Scholar
• Metformin mediated PD-L1 downregulation in combination with photodynamic-immunotherapy for treatment of breast cancer. Adv Funct Mater. 2021;31:2007149.
   Google Scholar
• Zhu K, Liu Y, Wang H, et al. Xanthate-modified silica as a novel multifunctional additive for properties improvement of natural rubber. Compos Sci Technol. 2021;203:108567. doi: 10.1016/j.compscitech.2020.108567.
   Web of Science ®Google Scholar
• Silvester E, Truccolo D, Hao FP. Kinetics and mechanism of the oxidation of ethyl xanthate and ethyl thiocarbonate by hydrogen peroxide. J Chem Soc. 2002;2:1562–1571.
   Google Scholar
• Tanhaei B, Ayati A, Sillanpää M. Magnetic xanthate modified chitosan as an emerging adsorbent for cationic azo dyes removal: kinetic, thermodynamic and isothermal studies. Int J Biol Macromol. 2019;121:1126–1134. doi: 10.1016/j.ijbiomac.2018.10.137.
   PubMed Web of Science ®Google Scholar
• Foroutan A, Abbas Zadeh Haji Abadi M, Kianinia Y, et al. Critical importance of pH and collector type on the flotation of sphalerite and galena from a low-grade lead-zinc ore. Sci Rep. 2021;11(1):3103. doi: 10.1038/s41598-021-82759-3.
   PubMed Web of Science ®Google Scholar
• Shen Z, Ma N, Wang F, et al. pH- and H2O2-sensitive drug delivery system based on sodium xanthate: dual-responsive supramolecular vesicles from one functional group. Chin Chem Lett. 2022;33(10):4563–4566. doi: 10.1016/j.cclet.2022.01.069.
   Web of Science ®Google Scholar
• Biswas S. Polymeric micelles as drug-delivery systems in cancer: challenges and opportunities. Nanomedicine. 2021;16(18):1541–1544. doi: 10.2217/nnm-2021-0081.
   PubMed Web of Science ®Google Scholar
• Noel P, Von Hoff DD, Saluja AK, et al. Triptolide and its derivatives as cancer therapies. Trends Pharmacol Sci. 2019;40(5):327–341. doi: 10.1016/j.tips.2019.03.002.
   PubMed Web of Science ®Google Scholar
• Sai K, Li WY, Chen YS, et al. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-kappaB signaling in glioma initiating cells. Am J Chin Med. 2014;42(2):485–503. doi: 10.1142/S0192415X14500323.
   PubMed Web of Science ®Google Scholar
• Dong X, Brahma RK, Fang C, et al. Stimulus-responsive self-assembled prodrugs in cancer therapy. Chem Sci. 2022;13(15):4239–4269. doi: 10.1039/d2sc01003h.
   PubMed Web of Science ®Google Scholar
• Chawla SP, Goel S, Chow W, et al. A phase 1b dose escalation trial of NC-6300 (nanoparticle epirubicin) in patients with advanced solid tumors or advanced, metastatic, or unresectable soft-tissue sarcoma. Clin Cancer Res. 2020;26(16):4225–4232. doi: 10.1158/1078-0432.CCR-20-0591.
   PubMed Web of Science ®Google Scholar
• Mukai H, Kogawa T, Matsubara N, et al. A first-in-human phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors. Invest New Drugs. 2017;35(3):307–314. doi: 10.1007/s10637-016-0422-z.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Fukushima S, Okamoto K, et al. Development of the polymer micelle carrier system for doxorubicin. J Control Release. 2001;74(1–3):295–302. doi: 10.1016/s0168-3659(01)00341-8.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Hamaguchi T, Ura T, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer. 2004;91(10):1775–1781. doi: 10.1038/sj.bjc.6602204.
   PubMed Web of Science ®Google Scholar
• Atrafi F, Dumez H, Mathijssen RHJ, et al. A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours. J Control Release. 2020;325:191–197. doi: 10.1016/j.jconrel.2020.06.020.
   PubMed Web of Science ®Google Scholar
• Boere I, Vergote I, Hanssen R, et al. CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer. Int J Gynecol Cancer. 2023;33(8):1247–1252. doi: 10.1136/ijgc-2023-004308.
   PubMed Web of Science ®Google Scholar
• Piha-Paul SA, Thein KZ, De Souza P, et al. First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies. Invest New Drugs. 2021;39(4):1047–1056. doi: 10.1007/s10637-021-01081-x.
   PubMed Web of Science ®Google Scholar
• Voss MH, Hussain A, Vogelzang N, et al. A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma. Ann Oncol. 2017;28(11):2754–2760. doi: 10.1093/annonc/mdx493.
   PubMed Web of Science ®Google Scholar
• Gayam SR, Venkatesan P, Sung YM, et al. An NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme responsive nanocarrier based on mesoporous silica nanoparticles for tumor targeted drug delivery in vitro and in vivo. Nanoscale. 2016;8(24):12307–12317. doi: 10.1039/c6nr03525f.
   PubMed Web of Science ®Google Scholar
• Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504–1534. doi: 10.1002/adma.201104763.
   PubMed Web of Science ®Google Scholar
• Xie M, Shi H, Li Z, et al. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging. Colloids Surf B Biointerfaces. 2013;110:138–147. doi: 10.1016/j.colsurfb.2013.04.009.
   PubMed Web of Science ®Google Scholar
• Li J, Du X, Zheng N, et al. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity. Colloids Surf B Biointerfaces. 2016;141:374–381. doi: 10.1016/j.colsurfb.2016.02.009.
   PubMed Web of Science ®Google Scholar
• Yang C, Shi Z, Feng C, et al. An adjustable pH-responsive drug delivery system based on self-assembly polypeptide-modified mesoporous silica. Macromol Biosci. 2020;20(6):e2000034.
   PubMed Web of Science ®Google Scholar
• Chen C, Sun W, Wang X, et al. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release. Mater Sci Eng C Mater Biol Appl. 2018;85:88–96. doi: 10.1016/j.msec.2017.12.007.
   PubMed Web of Science ®Google Scholar
• Manatunga DC, Godakanda VU, Silva RM, et al. Recent developments in the use of organic–inorganic nanohybrids for drug delivery. WIREs Nanomed Nanobiotechnol. 2019;12(3):e1605. doi: 10.1002/wnan.1605.
   Google Scholar
• Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials. 2013;34(4):1213–1222. doi: 10.1016/j.biomaterials.2012.08.072.
   PubMed Web of Science ®Google Scholar
• Yang H, Chen Y, Chen Z, et al. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites. Biomater Sci. 2017;5(5):1001–1013. doi: 10.1039/c7bm00043j.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ballester NM, Bataille B, Soulairol I. Sodium alginate and alginic acid as pharmaceutical excipients for tablet formulation: structure-function relationship. Carbohydr Polym. 2021;270:118399. doi: 10.1016/j.carbpol.2021.118399.
   PubMed Web of Science ®Google Scholar
• Li Z, Guo J, Qi G, et al. pH-responsive drug delivery and imaging study of hybrid mesoporous silica nanoparticles. Molecules. 2022;27(19):6519. doi: 10.3390/molecules27196519.
   Web of Science ®Google Scholar
• Maleki Dizaj S, Sharifi S, Ahmadian E, et al. An update on calcium carbonate nanoparticles as cancer drug/gene delivery system. Expert Opin Drug Deliv. 2019;16(4):331–345. doi: 10.1080/17425247.2019.1587408.
   PubMed Web of Science ®Google Scholar
• Peng H, Li K, Wang T, et al. Preparation of hierarchical mesoporous CaCO3 by a facile binary solvent approach as anticancer drug carrier for etoposide. Nanoscale Res Lett. 2013;8(1):321. doi: 10.1186/1556-276X-8-321.
   PubMed Web of Science ®Google Scholar
• Liang P, Liu CJ, Zhuo RX, et al. Self-assembled inorganic/organic hybrid nanoparticles with multi-functionalized surfaces for active targeting drug delivery. J Mater Chem B. 2013;1(34):4243–4250. doi: 10.1039/c3tb20455c.
   PubMed Web of Science ®Google Scholar
• Xiong HM. ZnO nanoparticles applied to bioimaging and drug delivery. Adv Mater. 2013;25(37):5329–5335. doi: 10.1002/adma.201301732.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Xu YD, Ma YY, et al. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro. Angew Chem Int Ed Engl. 2013;52(15):4127–4131. doi: 10.1002/anie.201300431.
   PubMed Web of Science ®Google Scholar
• Huang S, Laoukili J, Epping MT, et al. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell. 2009;15(4):328–340. doi: 10.1016/j.ccr.2009.02.023.
   PubMed Web of Science ®Google Scholar
• Matthay KK, Reynolds CP, Seeger RC, et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children’s oncology group study. J Clin Oncol. 2009;27(7):1007–1013. doi: 10.1200/JCO.2007.13.8925.
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singla S, et al. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. Mol Pharm. 2013;10(5):1958–1963. doi: 10.1021/mp300722f.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47(1):139–151. doi: 10.1016/j.ejps.2012.05.010.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wei JS, Zhang P, et al. Self-assembled ZnO nanoparticle capsules for carrying and delivering isotretinoin to cancer cells. ACS Appl Mater Interfaces. 2017;9(22):18474–18481. doi: 10.1021/acsami.7b02542.
   PubMed Web of Science ®Google Scholar
• Ye DX, Ma YY, Zhao W, et al. ZnO-based nanoplatforms for labeling and treatment of mouse tumors without detectable toxic side effects. ACS Nano. 2016;10(4):4294–4300. doi: 10.1021/acsnano.5b07846.
   PubMed Web of Science ®Google Scholar
• Takakura Y, Takagi A, Hashida M, et al. Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm Res. 1987;4(4):293–300. doi: 10.1023/a:1016489002393.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin J, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011;49:986–995.
   Web of Science ®Google Scholar
• Zhao X, Liu L, Li X, et al. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin. Langmuir. 2014;30(34):10419–10429. doi: 10.1021/la502952f.
   PubMed Web of Science ®Google Scholar
• Zhao X, Yang L, Li X, et al. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem. 2015;26(1):128–136. doi: 10.1021/bc5005137.
   PubMed Web of Science ®Google Scholar
• Kyu Shim M, Yang S, Sun IC, et al. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer immunotherapy: preclinical evidence for safe and effective drug delivery. Adv Drug Deliv Rev. 2022;183:114177. doi: 10.1016/j.addr.2022.114177.
   PubMed Web of Science ®Google Scholar
• Fu S, Li G, Zang W, et al. Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharm Sin B. 2022;12(1):92–106. doi: 10.1016/j.apsb.2021.08.012.
   PubMed Web of Science ®Google Scholar
• Huang P, Wang D, Su Y, et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc. 2014;136(33):11748–11756. doi: 10.1021/ja505212y.
   PubMed Web of Science ®Google Scholar
• Fang Q, Xu X, Yang L, et al. Self-assembled 5-fluorouracil-cinnamaldehyde nanodrugs for greatly improved chemotherapy in vivo. J Biomater Appl. 2021;36(4):592–604. doi: 10.1177/0885328221989539.
   PubMed Web of Science ®Google Scholar
• Zou L, Liu X, Li J, et al. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Theranostics. 2021;11(9):4171–4186. doi: 10.7150/thno.42260.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wei W, Chen X, et al. pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy. Nanomedicine. 2019;20:102008. doi: 10.1016/j.nano.2019.04.011.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Liu J, Guo M, et al. Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance. Nanoscale. 2018;10(26):12639–12649. doi: 10.1039/c8nr02700e.
   PubMed Web of Science ®Google Scholar
• Fan Z, Wang Y, Xiang S, et al. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects. J Mater Chem B. 2020;8(9):1922–1934. doi: 10.1039/d0tb00049c.
   PubMed Web of Science ®Google Scholar
• Li X, Yu N, Li J, et al. Novel “carrier-free” nanofiber codelivery systems with the synergistic antitumor effect of paclitaxel and tetrandrine through the enhancement of mitochondrial apoptosis. ACS Appl Mater Interfaces. 2020;12(9):10096–10106. doi: 10.1021/acsami.9b17363.
   PubMed Web of Science ®Google Scholar
• Wang J, Qiao W, Zhao H, et al. Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles. Biochem Pharmacol. 2020;182:114232. doi: 10.1016/j.bcp.2020.114232.
   PubMed Web of Science ®Google Scholar
• Yan G, Chen R, Xiong N, et al. pH-sensitive small molecule nanodrug self-assembled from amphiphilic vitamin B6-E analogue conjugate for targeted synergistic cancer therapy. Colloids Surf B Biointerfaces. 2020;191:111000. doi: 10.1016/j.colsurfb.2020.111000.
   PubMed Web of Science ®Google Scholar
• Gao J, Qiao Z, Liu S, et al. A small molecule nanodrug consisting of pH-sensitive ortho ester-dasatinib conjugate for cancer therapy. Eur J Pharm Biopharm. 2021;163:188–197. doi: 10.1016/j.ejpb.2021.04.008.
   PubMed Web of Science ®Google Scholar
• Lan JS, Qin YH, Liu L, et al. A carrier-free folate receptor-targeted ursolic acid/methotrexate nanodelivery system for synergetic anticancer therapy. Int J Nanomedicine. 2021;16:1775–1787. doi: 10.2147/IJN.S287806.
   PubMed Web of Science ®Google Scholar
• Mei H, Li J, Cai S, et al. Mitochondria-acting carrier-free nanoplatform self-assembled by alpha-tocopheryl succinate carrying cisplatin for combinational tumor therapy. Regen Biomater. 2021;8(4):rbab029.
   PubMed Web of Science ®Google Scholar
• Yang L, Xu J, Xie Z, et al. Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo. Asian J Pharm Sci. 2021;16(6):762–771. doi: 10.1016/j.ajps.2021.08.001.
   PubMed Web of Science ®Google Scholar
• Xin C, Zhang Y, Bao M, et al. Novel carrier-free, charge-reversal and DNA-affinity nanodrugs for synergistic cascade cancer chemo-chemodynamic therapy. J Colloid Interface Sci. 2022;606(Pt 2):1488–1508. doi: 10.1016/j.jcis.2021.08.121.
   PubMedGoogle Scholar
• Hassan S, Prakash G, Ozturk A, et al. Evolution and clinical translation of drug delivery nanomaterials. Nano Today. 2017;15:91–106. doi: 10.1016/j.nantod.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921–r925. doi: 10.1016/j.cub.2020.06.081.
   PubMed Web of Science ®Google Scholar
• Peng S, Xiao F, Chen M, et al. Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy. Adv Sci. 2022;9(1):e2103836. doi: 10.1002/advs.202103836.
   Web of Science ®Google Scholar
• Morarasu S, Morarasu BC, Ghiarasim R, et al. Targeted cancer therapy via pH-functionalized nanoparticles: a scoping review of methods and outcomes. Gels. 2022;8(4):232. doi: 10.3390/gels8040232.
   PubMed Web of Science ®Google Scholar
• Karaosmanoglu S, Zhou M, Shi B, et al. Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release. 2021;329:805–832. doi: 10.1016/j.jconrel.2020.10.014.
   PubMed Web of Science ®Google Scholar
• Yang MY, Zhao RR, Fang YF, et al. Carrier-free nanodrug: a novel strategy of cancer diagnosis and synergistic therapy. Int J Pharm. 2019;570:118663. doi: 10.1016/j.ijpharm.2019.118663.
   PubMed Web of Science ®Google Scholar
• Li B, Shao H, Gao L, et al. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv. 2022;29(1):2130–2161. doi: 10.1080/10717544.2022.2094498.
   PubMed Web of Science ®Google Scholar
• Cui T, Zhang S, Sun H. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Oncol Rep. 2017;37(2):1253–1260. doi: 10.3892/or.2017.5345.
   PubMed Web of Science ®Google Scholar
• Martínez-Edo G, Fornaguera C, Borrós S, et al. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles for the Co-delivery of DOX/CPT-PEG for targeting HepG2 cells. Pharmaceutics. 2020;12(11):1048. doi: 10.3390/pharmaceutics12111048.
   PubMed Web of Science ®Google Scholar
• Younis MA, Tawfeek HM, Abdellatif AAH, et al. Clinical translation of nanomedicines: challenges, opportunities, and keys. Adv Drug Deliv Rev. 2022;181:114083. doi: 10.1016/j.addr.2021.114083.
   PubMedGoogle Scholar